QQ客服 官方微博 反馈留言

浏览/检索结果: 共210条，第1-10条 帮助 限定条件 发表日期：2018    专题：中国医学科学院 北京协和医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Postoperative Radiation Therapy Improves Survivals of Resected Pathological Stage IIIA-N2 Non-Small Cell Lung Cancer: A Retrospective Study of 1434 Cases from a Single Institution 期刊论文 2018, 卷号: 102, 期号: 3, 页码: E685-E685 作者:  Hui, Z.;  Men, Y.;  Kang, J.;  Sun, X.;  Liang, J. 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/03 Re-biopsy status among Chinese non-small-cell lung cancer patients who progressed after icotinib therapy 期刊论文 2018, 卷号: 11, 页码: 7513-7519 作者:  Wang, Hanping;  Zhang, Li;  Si, Xiaoyan;  Zhang, Xiaotong;  Wang, Mengzhao 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03 re-biopsy  T790M mutation  resistant mechanism  EGFR-TKI  icotinib  non-small-cell lung cancer   Establishment of a prospective multicenter cohort for advanced non-small cell lung cancer in China (CAPTRA-Lung study) 期刊论文 2018, 卷号: 9, 期号: 12, 页码: 1795-1800 作者:  Xu, Yan;  Zhang, Li;  Fang, Jian;  Wang, Ziping;  Li, Junling 收藏  |  浏览/下载：6/0  |  提交时间：2020/01/03 Multicenter real-world study  non-small cell lung cancer  prospective observational cohort   Two plasma microRNA panels for diagnosis and subtype discrimination of lung cancer 期刊论文 2018, 卷号: 123, 页码: 44-51 作者:  Lu, Shaohua;  Kong, Hui;  Hou, Yingyong;  Ge, Di;  Huang, Wei 收藏  |  浏览/下载：9/0  |  提交时间：2020/01/03 Plasma microRNA  Lung cancer  Early diagnosis  Subtype discrimination   Alectinib treatment response in lung adenocarcinoma patient with novel EML4-ALK variant 期刊论文 2018, 卷号: 9, 期号: 10, 页码: 1327-1332 作者:  Song, Peng;  Zhang, Jingcheng;  Shang, Congcong;  Zhang, Li 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03 Alectinib  crizotinib  EML4-ALK  lung cancer   A consensus on immunotherapy from the 2017 Chinese Lung Cancer Summit expert panel 期刊论文 2018, 卷号: 7, 期号: 3, 页码: 428-436 作者:  Wu, Yi-Long;  Wang, Chang-Li;  Liao, Mei-Lin;  Guan, Zhong-Zhen;  Gao, Chen-Yan 收藏  |  浏览/下载：10/0  |  提交时间：2020/01/03 Lung cancer  immunotherapy  consensus   The peripheral blood neutrophil-to-lymphocyte ratio is a prognostic predictor for survival of EGFR-mutant nonsmall cell lung cancer patients treated with EGFR-TKIs 期刊论文 2018, 卷号: 97, 期号: 30, 页码: e11648 作者:  Zhang, Yuan;  Feng, Yang-Chun;  Zhu, Hong-Ge;  Xiong, Ting-Chuan;  Hou, Yan-Shen 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03 epidermal growth factor receptor  lymphocyte-to-monocyte ratio  neutrophil-to-lymphocyte ratio  nonsmall cell lung cancer  tyrosine kinase inhibitors   Circulating microRNAs as Biomarkers of Radiation-Induced Cardiac Toxicity in Non-Small Cell Lung Cancer 期刊论文 2018, 卷号: 102, 期号: 3, 页码: S139-S139 作者:  Hawkins, P. G.;  Sun, Y.;  Dess, R. T.;  Jackson, W. C.;  Sun, G. 收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03 Postoperative Radiation Therapy (PORT) Is Safe and Effective in pIII-N2 Non-Small-Cell Lung Cancer (NSCLC) Receiving Pneumonectomy 期刊论文 2018, 卷号: 102, 期号: 3, 页码: E712-E713 作者:  Wang, W.;  Men, Y.;  Wang, J.;  Hui, Z.;  Wang, L. 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/03 Transbronchoscopic patient biopsy-derived xenografts as a preclinical model to explore chemorefractory-associated pathways and biomarkers for small-cell lung cancer 期刊论文 2018, 卷号: 440, 页码: 180-188 作者:  Wang, Zhijie;  Fu, Shuai;  Zhao, Jun;  Zhao, Wei;  Shen, Zhirong 收藏  |  浏览/下载：7/0  |  提交时间：2020/01/03 Transbronchoscopic patient biopsy-derived xenografts  Chemorefractory  Small-cell lung cancer  Mitogen-activated protein kinase  Receptor tyrosine kinase